e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Specific immunotherapy in rhintis / inflammatory markers in exhaled air
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cinical assessment of asthma severity partially corresponds to eosinophilic airway inflammation
M. L. E. Bartoli, E. Bacci, S. Carnevali, S. Cianchetti, F. L. Dente, A. Di Franco, D. Giannini, B. Vagaggini, P. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2002 - Specific immunotherapy in rhintis / inflammatory markers in exhaled air
Session:
Specific immunotherapy in rhintis / inflammatory markers in exhaled air
Session type:
Thematic Poster Session
Number:
3175
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. L. E. Bartoli, E. Bacci, S. Carnevali, S. Cianchetti, F. L. Dente, A. Di Franco, D. Giannini, B. Vagaggini, P. Paggiaro (Pisa, Italy). Cinical assessment of asthma severity partially corresponds to eosinophilic airway inflammation. Eur Respir J 2002; 20: Suppl. 38, 3175
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Association between eosinophilic airway inflammation and T-cells response in children with bronchial asthma
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Mepolizumab improves small airway function in severe eosinophilic asthma
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018
The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005
Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
The clinical importance of measuring airway inflammation
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Airway remodelling is present in children with asthma regardless of eosinophilic inflammation
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
The role of neutrophilic inflammation in asthma of different severity
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002
Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017
Upper airway symptoms associate with the eosinophilic phenotype of COPD
Source: ERJ Open Res, 7 (3) 00184-2021; 10.1183/23120541.00184-2021
Year: 2021
Outgrown asthma does not mean no airways inflammation
Source: Eur Respir J 2002; 19: 284-287
Year: 2002
Breathing training improves asthma symptoms but not airways inflammation or hyper-reactivity in asthma
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008
Alamandine reduces eosinophilic inflammation in an experimental model of asthma
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept